AKBA
Akebia Therapeutics, Inc. · Healthcare
CEO and President John P. Butler sold $81K of Akebia Therapeutics, Inc.
Sold$80,614
$0.88Price
91,868Shares
−5%Stake
What AKBA did after the filing
- The stock from Fri, Mar 3 open, $0.92
- −29.5%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Apr 17 close.
Traded Wed, Mar 1. Filed Fri, Mar 3, 3:01 AM ET, before the open. Returns use the Mar 3 open and the Apr 17 close. Not investment advice.